Kylo-02

N/A

Report date: 2025/03/18 14:44:57
NME

Base Information

Drug NameKylo-02
Drug Alias NameKylo-02
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHepatitis B virus replication inhibitorsHBsAg inhibitorsHepatitis B e Antigens inhibitors
TargetsHepatitis B Surface AntigensHepatitis B e Antigens
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXiamen Ganbaoli Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXiamen Ganbaoli Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A